BioSpace News Archive

First U.S. building to incorporate viscous wall dampers in case of “The Big One”

Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo” or the “Company”), today announced plans to conduct a conference call to provide a corporate update and respond to questions, particularly with respect to steps it is taking as a result of its discussions with representatives of the Coverage and Analysis Group (CAG) of the Centers for Medicare & Medicaid Services.

Company recognized for its strategic use of social media platforms

Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has elected to exercise its right under the warrant indenture (the “Indenture”) governing the common share purchase warrants of the Company issued October 30, 2017 and originally scheduled to expire on October 30, 2019

A study examining the effect of a video educational intervention aimed at increasing HPV vaccinations among adolescents could help the Centers for Disease Control and Prevention meet its goal of getting more eligible adolescents vaccinated against certain cancers and diseases caused by the human papillomavirus (HPV).

Mercom Capital Group, llc, a global communications and research firm, released its annual report on funding and mergers and acquisitions (M&A) activity for the Digital Health / Healthcare Information Technology (IT) sector for 2018.

Solentim, a global leader in Cell Line Development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement.

Stephanie Brooking to support Evonetix in developing its strategy for market entry

These new antibodies and thousands of other monoclonal/polyclonal antibodies and conjugates are validated for use in a variety of common applications such as WB, FC, IHC, ICC, IF, IP, and more.

Reading Scientific Services Ltd, a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical, and biopharmaceutical sectors, has introduced the United Kingdom’s first same-day mycoplasma testing service for manufacturers of biologic medicines.